跳至主要内容
临床试验/NCT00595062
NCT00595062已完成不适用

Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2002年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
1
主要终点
To determine tissue tolerance of the breast to a single intraoperative course of radiation.

研究概览

简要总结

This study was started to validate the possibility of administering radiation therapy during surgery to the tissue surrounding the tumor once the tumor has been removed. This surrounding breast tissue is at greater risk for developing breast recurrences. This treatment may be as effective as the conventional 5-6week radiation treatment in reducing the risk of further local recurrences after breast-conserving surgery.

Through this study, we would like to confirm that this procedure is a safe alternative to conventional breast radiation, with no additional side effects when compared with the conventional surgery and radiation therapy.

详细描述

This pilot trial will evaluate the feasibility of intra operative radiation therapy (IORT) given in one fraction at the time of wide local excision as the only adjuvant radiation treatment in a group of patients with early-stage invasive breast cancer.

This study will enroll 60 women, older than 60 years of age, with breast cancer not more than 2 cm in size and without evident additional tumoral foci around the tumor or in other areas of the breast. An MSK radiologist will review your mammography to be sure you qualify for this study. You may be asked to undergo additional mammography or other examinations, such as breast ultrasound in order to verify that the tumor is located in a single quadrant of the breast. Some of these procedures are routinely performed in all candidates for conservative breast surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Core biopsy or prior open biopsy to establish the diagnosis.
  • No physical or imaging evidence of multicentricity or multifocality.
  • Size equal or less than 2.0 cm radiographically, clinically node negative.
  • Patients scheduled for breast conserving surgery

排除标准

  • Patients younger than 61 years
  • Patients with evidence of multicentric or multifocal disease seen on imaging (mammography )
  • Patients with a lesion exceeding 2 cm radiographically
  • Paget's disease or pure DCIS without invasive ductal carcinoma
  • Histotype not inclusive of ductal carcinoma
  • Condition precluding radiation therapy
  • Condition precluding regular follow-up
  • Evident dimpling of the skin above the tumor
  • Usual contraindications for BCS

结局指标

主要结局

To determine tissue tolerance of the breast to a single intraoperative course of radiation.

时间窗: 7 years

To establish feasibility of the technique in the operating room.

时间窗: 7 years

次要结局

  • overall survival(7 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验